Skip to main content
. 2021 Jan 26;325(4):373–381. doi: 10.1001/jama.2020.25071

Table 1. Baseline Characteristics of Participants With TIA and Control Participants Without TIA.

Entire follow-up period (1948-2017) Current epoch (2000-2017)
With TIA (n = 435)a Without TIA (n = 2175) Absolute difference (95% CI) P value With TIA (n = 118) Without TIA (n = 590) Absolute difference (95% CI) P value
Age, mean (SD), y 71.9 (11.2) 71.3 (11.3) 0.55 (−0.61 to 1.71) .35 73.2 (13.4) 72.8 (13.3) 0.39 (−2.25 to 3.03) .77
Sex, No. (%)
Women 229 (53) 1145 (53) 0.00 (−0.05 to 0.05) >.99 65 (55) 325 (55) 0.00 (0.10 to 0.10) >.99
Men 206 (47) 1030 (47) 0.00 (−0.05 to 0.05) 53 (45) 265 (45) 0.00 (0.10 to 0.10)
Blood pressure, mean (SD), mm Hg
Systolic 144 (23) 136 (21) 7.17 (4.80 to 9.53)a <.001 135 (21) 130 (20) 4.20 (0.22 to 8.19)a .04
Diastolic 78 (13) 77 (11) 1.00 (0.29 to 2.29)a .13 73 (11) 73 (11) 0.25 (−1.88 to 2.37)a .82
Hypertension treatment, No./total (%) 198/422 (47) 700/2075 (34) 13.2 (8.0 to 18.4) <.001 67/115 (58) 248/584 (42) 15.8 (5.9 to 25.6) .002
Stage I hypertension, No./total (%) 315/430 (73) 1223/2156 (57) 16.5 (2.1 to 11.9) <.001 76/117 (65) 318/587 (54) 10.8 (1.2 to 20.3) .03
Diabetes mellitus, No./total (%) 59/346 (17) 198/1729 (11) 5.6 (1.4 to 9.8) .004 27/101 (27) 71/512 (14) 12.8 (3.7 to 22.0) .001
Atrial fibrillation, No. (%) 42 (10) 115 (5) 4.4 (1.4.32 to 7.3) .001 19 (16) 41 (7) 9.1 (2.2 to 16.1) .001
Current smoking, No./total (%) 100/409 (24) 397/1994 (20) 4.5 (0.2 to 9.0) .04 16 (14) 75/586 (13) 0.8 (−7.5 to 6.0) .82
Coronary heart disease, No. (%) 103 (24) 330 (15) 8.5 (4.2 to 12.8) <.001 23 (19) 71 (12) 7.5 (−0.2 to 15.1) .03

Abbreviation: TIA, transient ischemic attack.

a

For the continuous variables systolic and diastolic blood pressure, data are reported as absolute mean difference and corresponding 95% CI.